Novo Nordisk and Eli Lilly become latest drug companies to bend knee to Trump’s ‘most-favored nation’ pricing plan ...
US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices ...
Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.
Israeli Spyware Maker NSO Gets New Owners, Leadership and Seeks to Mend Reputation Investors led by Hollywood producer Robert Simonds have taken a controlling stake in the company behind Pegasus, and ...
President Donald Trump has long pushed to cut the price of GLP-1 medications, often expressing frustration about the high ...
Republican Chairman Ron Johnson excoriated ranking member Richard Blumenthal in a sprawling rant that transformed the hearing ...
A man who was reportedly taking weight loss medication appeared to collapse Thursday during a press conference to debut a ...
The Daily Overview on MSN
Pfizer buys Metsera for $10B after obesity drug bidding war
Pfizer has secured a $10 billion acquisition of obesity drug developer Metsera, outbidding rival Novo Nordisk in a heated ...
Concerns about the company's future growth are likely keeping investors away.
1don MSN
Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.
Pfizer is buying its way back into the obesity-drug game after fighting off a rival bid from Novo Nordisk to buy Metsera, ...
Pfizer's agreement to buy Metsera just adds to the 83 healthcare deals counted by Goldman Sachs that were above $100 million ...
The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results